Law ❯ Litigation ❯ Class Action Lawsuits ❯ Investor Representation

Contingency Fees

Soleno Therapeutics Investors Face May 5 Deadline to Seek Lead Role in Securities Class Action

The push highlights a fight over what Soleno told investors about its Prader‑Willi drug VYKAT XR.

Bitdeer Investors Face Feb. 2 Deadline in Securities Class Action Over SEAL04 Disclosures

James Hardie Investors Face Dec. 23 Deadline in Securities Suit Over Alleged Inventory Misstatements